Annual Cash & Cash Equivalents
$9.45 M
-$2.68 M-22.10%
December 31, 2023
Summary
- As of February 8, 2025, VTVT annual cash & cash equivalents is $9.45 million, with the most recent change of -$2.68 million (-22.10%) on December 31, 2023.
- During the last 3 years, VTVT annual cash & cash equivalents has risen by +$3.70 million (+64.36%).
- VTVT annual cash & cash equivalents is now -89.27% below its all-time high of $88.00 million, reached on December 31, 2015.
Performance
VTVT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$41.57 M
-$3.96 M-8.69%
September 30, 2024
Summary
- As of February 8, 2025, VTVT quarterly cash and cash equivalents is $41.57 million, with the most recent change of -$3.96 million (-8.69%) on September 30, 2024.
- Over the past year, VTVT quarterly cash and cash equivalents has dropped by -$3.96 million (-8.69%).
- VTVT quarterly cash and cash equivalents is now -57.15% below its all-time high of $97.01 million, reached on September 30, 2015.
Performance
VTVT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
VTVT Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -22.1% | -8.7% |
| 3 y3 years | +64.4% | +229.9% |
| 5 y5 years | +461.3% | +550.4% |
VTVT Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -29.6% | at low | -20.4% | +404.6% |
| 5 y | 5-year | -29.6% | +431.6% | -20.4% | >+9999.0% |
| alltime | all time | -89.3% | +767.4% | -57.1% | >+9999.0% |
VTv Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $41.57 M(-8.7%) |
| Jun 2024 | - | $45.53 M(-12.9%) |
| Mar 2024 | - | $52.26 M(+453.2%) |
| Dec 2023 | $9.45 M(-22.1%) | $9.45 M(+14.7%) |
| Sep 2023 | - | $8.24 M(-34.6%) |
| Jun 2023 | - | $12.60 M(-32.9%) |
| Mar 2023 | - | $18.77 M(+54.8%) |
| Dec 2022 | $12.13 M(-9.6%) | $12.13 M(-20.9%) |
| Sep 2022 | - | $15.34 M(-14.1%) |
| Jun 2022 | - | $17.86 M(+47.2%) |
| Mar 2022 | - | $12.14 M(-9.5%) |
| Dec 2021 | $13.41 M(+133.4%) | $13.41 M(-31.4%) |
| Sep 2021 | - | $19.57 M(+80.6%) |
| Jun 2021 | - | $10.84 M(+28.2%) |
| Mar 2021 | - | $8.45 M(+47.0%) |
| Dec 2020 | $5.75 M(+223.4%) | $5.75 M(+214.6%) |
| Sep 2020 | - | $1.83 M(-71.4%) |
| Jun 2020 | - | $6.39 M(+1474.4%) |
| Mar 2020 | - | $406.00 K(-77.2%) |
| Dec 2019 | $1.78 M | $1.78 M(-27.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $2.44 M(+66.6%) |
| Jun 2019 | - | $1.46 M(-70.5%) |
| Mar 2019 | - | $4.96 M(+194.7%) |
| Dec 2018 | $1.68 M(-85.7%) | $1.68 M(-55.3%) |
| Sep 2018 | - | $3.77 M(+223.8%) |
| Jun 2018 | - | $1.16 M(-82.2%) |
| Mar 2018 | - | $6.54 M(-44.4%) |
| Dec 2017 | $11.76 M(-77.2%) | $11.76 M(-42.6%) |
| Sep 2017 | - | $20.49 M(-37.0%) |
| Jun 2017 | - | $32.51 M(-28.0%) |
| Mar 2017 | - | $45.15 M(-12.3%) |
| Dec 2016 | $51.51 M(-41.5%) | $51.51 M(+0.9%) |
| Sep 2016 | - | $51.06 M(-20.0%) |
| Jun 2016 | - | $63.84 M(-15.4%) |
| Mar 2016 | - | $75.50 M(-14.2%) |
| Dec 2015 | $88.00 M(+6258.6%) | $88.00 M(-9.3%) |
| Sep 2015 | - | $97.01 M(+3947.1%) |
| Jun 2015 | - | $2.40 M(+208.9%) |
| Mar 2015 | - | $776.00 K(-43.9%) |
| Dec 2014 | $1.38 M(+27.1%) | $1.38 M |
| Dec 2013 | $1.09 M | - |
FAQ
- What is vTv Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for vTv Therapeutics?
- What is vTv Therapeutics annual cash & cash equivalents year-on-year change?
- What is vTv Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for vTv Therapeutics?
- What is vTv Therapeutics quarterly cash and cash equivalents year-on-year change?
What is vTv Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of VTVT is $9.45 M
What is the all time high annual cash & cash equivalents for vTv Therapeutics?
vTv Therapeutics all-time high annual cash & cash equivalents is $88.00 M
What is vTv Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, VTVT annual cash & cash equivalents has changed by -$2.68 M (-22.10%)
What is vTv Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of VTVT is $41.57 M
What is the all time high quarterly cash and cash equivalents for vTv Therapeutics?
vTv Therapeutics all-time high quarterly cash and cash equivalents is $97.01 M
What is vTv Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, VTVT quarterly cash and cash equivalents has changed by -$3.96 M (-8.69%)